About Endocrine Oncology
Endocrine Oncology is a peer-reviewed journal, publishing basic, translational and clinical research and reviews on the interplay between hormones and cancer, and related topics.
Publisher: Katherine Bryer
Endocrine Oncology is a fully gold open-access journal. Articles are published under a Creative Commons Attribution (CC BY) licence. Articles are freely available to everyone to read and reuse immediately upon publication, provided the terms of the licence are met.
For more information, please see our Open Access page
- Time to first decision: Endocrine Oncology aims to return a decision on a peer-reviewed article within two weeks
- Time to online publication: Accepted manuscripts are published online and are fully citable within 24 hours of acceptance
Articles published in Endocrine Oncology undergo peer review before acceptance. Key facts about the peer-review process are given below:
- identity transparency: single anonymized
- reviewer interacts with: editor
- review information published: none
If an article is not accepted for publication, we may offer the author the opportunity to transfer their submission to other suitable journals published by Bioscientifica.
More information about the peer-review process can be found on our Peer-review process page.
Endocrine Oncology publishes the following types of article:
- Research Articles
- Guidelines and Recommendations
- Letters to the Editor
- Brief Reports
- Case Reports
Authors can find all the information needed to prepare articles for submission to Endocrine Oncology on our Author Guidelines page.
Once an article is ready to submit, authors are advised to visit our How to Submit page page.
Submissions are managed though the Endocrine Oncology ScholarOne Manuscripts site.
Endocrine Oncology has the following publication charges:
- Article Publication Charge: Bioscientifica is currently sponsoring the Article Publication Charge; as such authors can publish completely free of charge*.
- Colour charges: There are no colour costs charged when publishing in Endocrine Oncology.
Endocrine Oncology maintains the highest standards of publication and research ethics and is a member of the Committee for Publication Ethics (COPE).
Authors, Reviewers and Editors are expected to comply with Bioscientifica’s Ethical Policy.
Endocrine Oncology recognises that there are biases and inequalities in the publishing system. We are committed to scrutinising our own processes and policies to prevent bias, reduce inequality and better represent and serve our diverse community of authors, reviewers, editors and readers.
Endocrine Oncology supports open data and strongly encourages authors to publicly release all data supporting the analysis and conclusions of primary research articles, on or before publication of the article.
All primary research articles published in Endocrine Oncology should include a Data Availability Statement.
More information is on our Research data page.
Endocrine Oncology is indexed in the following:
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- PubMed and PubMed Central
Applications will be made for Endocrine Oncology to be indexed in Emerging Sources Citation Index (ESCI; Journal Citation Reports) and MEDLINE once enough articles have been published, and/or the minimum acceptance criteria have been met.
Articles published in Endocrine Oncology are archived in LOCKSS and Portico to ensure that these articles are preserved in the long term.